4[1]Tabarki B, Mahdhaoui A,Selmi H,et al.Kawasaki disease with predominant central nervous system involvement.Pediatr Neurol,2001,25(3): 239- 241.
5[2]Poon LK,Lun KS,Ng YM.Facial nerve palsy and Kawasaki disease.Hong Kong Med J,2000,6(2): 224- 226.
6[3]Leung DY.The immunologic effects of IVIG in Kawa- saki disease.Int Rev Immunol,1989,5: 197- 202.
7Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin [J]. N Engl J Med, 1986, 315(6): 341-347.
8Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose [J]. J Pediatr, 1997, 131(6): 888-893.
9Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children [J]. Circulation, 1993, 87(5): 1776-1780.
10Rowley AH, Shulman ST. Kawasaki Disease [A]. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics [M]. 16th ed. Philadeiphia: Saunders, 2000, 725-727.
5Rowley A H, Shulman S T. Kawasaki Disease [ M ]//Behrman R E,Kliegman R M ,Arvin A M. Nelson Textbook of Pedrstics. 16th ed. Philadeiphia ; Sunders ,2000:725-727.
6Newburger J W, Takahashi M, Burns J C, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin[J]. N Engl J Med,1986,315(6) :341-347.
